AMBU ANNOUNCES NEW CHIEF OPERATIONS OFFICER
Henrik Birk steps down from his position as Chief Operations Officer at Ambu. Former Novozymes COO, Graziela Malucelli, takes on the position, effective immediately.

Effective today, Ambu appoints Graziela Malucelli as the company’s new Chief Operations Officer (COO). She succeeds Henrik Birk who will regrettably be stepping down, due to personal circumstances, a decision made with the support of Ambu’s Executive Management.
During Henrik Birk’s time at Ambu, he has been a truly respected leader with a great impact on Ambu teams and operations worldwide. However, given Henrik’s pressing personal priorities, he and CEO Britt Meelby Jensen have collaboratively agreed that this transition serves the best interests of both Henrik and the organisation.
“I am sad to be saying goodbye to Henrik, and I extend my heartfelt gratitude to him for his positive impact on Ambu. As Graziela Malucelli steps into the COO role, I am thrilled that we have been able to secure such a highly accomplished leader. I am confident that Graziela’s dynamic leadership and extensive operational expertise will take our organisation to the next level, as she leverages her extensive capabilities and expertise in driving global operations at scale.”
BRITT MEELBY JENSEN
Chief Executive Officer
Highly experienced COO to spearhead Ambu’s global operations
Taking on the role as Chief Operations at Ambu will be Graziela Malucelli, former COO at Novozymes. At Ambu, Graziela will step into Ambu’s Executive Leadership Team, dedicated to leading Ambu’s global operations teams and ensuring efficient innovation scale-up, reliable market supply and sustainable profitable growth.
Graziela is a highly experienced operational leader, possessing 25 years of experience leading large-scale operational teams across Europe, Asia-Pacific, Latin-America and North America. During her decades-long and notable career at Novozymes, she has held several key leadership roles. In her most recent position as COO, she successfully drove profitable growth and operational excellence across more than 15 global sites, supplying customers with innovative solutions to 140 markets and leading over 3,500 team members.
Above all, she is a purpose-driven and forward-thinking leader, with a strong strategic mindset, a keen customer focus and a passion for driving transformational change. Alongside her results-oriented leadership approach, she has a proven track-record of fostering engaged and collaborative global teams, and she is excited to join Ambu to make her mark on the company’s growth journey:
“I’m honoured and excited to take on the position as COO and to get the opportunity to contribute with my experience to strengthen Ambu’s position as the leader in single-use endoscopy, in our shared efforts to save lives. Together with Britt Meelby Jensen, the Executive Leadership Team and the talented Ambu colleagues, I am looking forward to bringing innovative healthcare solutions to patients and healthcare providers around the world.”
GRAZIELA MALUCELLI
New Chief Operations Officer
Keywords
Contacts
Tine Bjørn SchmidtHead of Corporate Communications
Tel:+45 2264 0697tisc@ambu.comAnders HjortHead of Investor Relations
Tel:+45 2892 8881anhj@ambu.comDocuments
About Ambu
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,600 people in Europe, North America, Latin America and Asia Pacific. For more information, please visit Ambu.com.
Subscribe to releases from Ambu A/S
Subscribe to all the latest releases from Ambu A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Ambu A/S
AMBU OBTAINS FDA CLEARANCE FOR FIRST-EVER SINGLE-USE FLEXIBLE CYSTO-NEPHROSCOPY SOLUTION19.6.2025 16:43:47 CEST | Press release
The FDA clearance for the Ambu® aScope™ 5 Cysto HD marks a historic milestone as the first ever single-use cysto-nephroscope to receive such clearance in the US. It follows the CE mark in Europe earlier this year, representing an important step forward in endoscopic technology and reinforcing Ambu’s commitment to innovation and advancement in urology care.
AMBU LAUNCHES FIRST-OF-ITS-KIND ENDOSCOPE RECYCLING PROGRAM TO ENHANCE WASTE REDUCTION IN HOSPITALS2.6.2025 10:27:09 CEST | Press release
Today, Ambu announces the launch of its new Ambu® Recircle program, teaming up with hospitals in both the US and the UK as the first key participants.
AMBU® SURESIGHT™ CONNECT VIDEO LARYNGOSCOPE EXPANDS WITH PAEDIATRIC BLADE OPTIONS12.5.2025 16:44:13 CEST | Press release
Ambu has expanded its newly launched Ambu® SureSight™ Connect video laryngoscopy solution with the introduction of five new blades designed specifically for paediatric patients.
AMBU APPOINTS NEW CHIEF MARKETING OFFICER1.5.2025 09:30:00 CEST | Press release
Jesper Johnsen Steen has been appointed as Ambu’s new Chief Marketing Officer, effective 1 May 2025.
AMBU EXPANDS CE MARK FOR EXISTING UROLOGY SOLUTION, ENABLES NEW TYPE OF PROCEDURE19.2.2025 10:41:31 CET | Press release
With the CE mark expansion for Ambu® aScope™ 5 Cysto HD, urologists will now be able to use the medical technology as a single-use flexible cysto-nephroscopy solution, reflecting Ambu’s commitment to addressing a growing range of urology needs for patients and healthcare professionals.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom